Genesis

A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline
Endpoints
Wed, 12/2/20 - 10:43 am
Genesis
artificial intelligence
Genentech
St. Jude's Genesis Wins CE Mark
Fri, 09/9/11 - 05:56 pm
St. Jude
Genesis
CE Mark
Genesis Pharmaceuticals Successfully Defends Itself in a Multi-Million Dollar Arbitration, Two Other Arbitration Proceedings Against Genesis are Withdrawn
Trading Markets
Sat, 02/7/09 - 11:08 am
Genesis